“There is very little data to justify how these drugs are being used and why they should be in the top 10 in sales,” a researcher said.
from Health https://nyti.ms/2WdLQAy
May 20, 2019
Rose
Health, Health - The New York Times
No comments
Related Posts:
For Many Boys With Duchenne Muscular Dystrophy, Bright Hope Lies Just Beyond ReachScientists are testing nearly two dozen treatments that might stop the disease. But enrollment in the trials is very restricted, and few children qualify. from Health https://ift.tt/2FC2yPV … Read More
Depressed and Anxious? These Video Games Want to HelpA growing number of games are taking on mental health issues like depression, anger and post-traumatic stress disorder. from Health https://ift.tt/2Fnw1wP … Read More
Medicare for All Would Abolish Private Insurance. ‘There’s No Precedent in American History’Unlike Obamacare, emerging plans would sweep away the private health insurance system. What would that mean for the companies’ workers, the stock market and the cost of care? from Health https://ift.tt/2UZ1NGI … Read More
My Friend’s Cancer Taught Me About a Hole in Our Health SystemCaregivers aren’t supported, and America overlooks their importance. from Health https://ift.tt/2TUR83v … Read More
Reading to Your Toddler? Print Books Are Better Than Digital Ones“The tablet itself made it harder for parents and children to engage in the rich back-and-forth turn-taking that was happening in print books,” a researcher said. from Health https://ift.tt/2Owsuk1 … Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment